In metabolically active tissues, fatty-acid handling may involve CD36, plasma-membrane fatty-acid-binding protein, and fatty-acid transport proteins, although their relative contribution depends on tissue and physiological state
Media Inquiries Forward-looking Statements Except for historical information, all of the statements, expectations and assumptions contained in this news release are forward-looking statements that involve a number of risks and uncertainties, including statements regarding expected benefits of products and product features
to 3 p.m
All study participants were randomly assigned to an experimental treatment group that received subcutaneous injection of cagrilintide, once-weekly, in doses of either 0.3, 0.6, 1.2, 2.4, or 4.5 mg, as well as a one-daily 3.0 mg dose of liraglutide, and a volume matched placebo for control purposes